Medtronic (NYSE:MDT) said it has received European approval for its disposable continuous glucose monitor, the MidiMed 780G system with Simplera Sync sensor. The medical device maker said it was ...

Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and ...

Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...

Medtronic will host a video webcast at 7:00 a.m. CST on November 19, 2024, to discuss results for its second quarter of full fiscal year 2025. The webcast can be accessed at ...

which makes patient monitoring systems that include pulse oximetry technology; and CVS and Walgreens, which sell over-the-counter pulse oximeters that are not cleared by the FDA. Medtronic holds a ...

That person already used an insulin pump from Medtronic and is now using the glucose monitoring system from Medtronic as well. And after about one week, I find the results impressive. The ...

GALWAY, Ireland, Nov. 5, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of ...

Martin de Bock receives funding from Novo Nordisk, Medtronic, Ypsomed ... Pharmac’s decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately ...

Medtronic (MDT) closed the latest trading day at $89.36, indicating a +0.57% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 0.61%. Meanwhile ...

Medtronic has issued a voluntary recall on some of its insulin pumps over concerns about the length of their battery life. The Dublin-based medical-device maker said Friday that customers of its ...

Shares of Medtronic PLC MDT shed 1.38% to $87.04 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.96% to 5,695.94 and Dow ...